CRL
Price:
$187.51
Market Cap:
$9.03B
Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending globally across the United States, Europe, Canada, and the Asia Pacific region. The company organizes its diverse offerings into three principal segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 1. Research Models and Services (RMS): This division is a key supplier of high-quality rodent...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2000-06-23
Stock Exchange
NYSE
Ticker
CRL
According to Charles River Laboratories International, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -50.54. This represents a change of 182.84% compared to the average of -17.87 of the last 4 quarters.
The mean historical PE Ratio of Charles River Laboratories International, Inc. over the last ten years is 110.85. The current -50.54 PE Ratio has changed -4659.37% with respect to the historical average. Over the past ten years (40 quarters), CRL's PE Ratio was at its highest in in the March 2025 quarter at 77.38. The PE Ratio was at its lowest in in the March 2026 quarter at -131.22.
Average
110.85
Median
27.53
Minimum
-69.93
Maximum
928.90
Discovering the peaks and valleys of Charles River Laboratories International, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.54%
Maximum Annual PE Ratio = 928.90
Minimum Annual Increase = -107.53%
Minimum Annual PE Ratio = -69.93
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -69.93 | -107.53% |
| 2024 | 928.90 | 3.54% |
| 2023 | 25.52 | 12.05% |
| 2022 | 22.77 | -53.02% |
| 2021 | 48.47 | 42.61% |
| 2020 | 33.98 | 15.05% |
| 2019 | 29.54 | 23.22% |
| 2018 | 23.97 | -43.10% |
| 2017 | 42.13 | 82.02% |
| 2016 | 23.14 | -7.54% |
The current PE Ratio of Charles River Laboratories International, Inc. (CRL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
294.83
5-year avg
191.14
10-year avg
110.85
Charles River Laboratories International, Inc.’s PE Ratio is less than Qiagen N.V. (19.08), less than Bio-Rad Laboratories, Inc. (45.67), less than Baxter International Inc. (-9.78), less than Avantor, Inc. (-11.55), less than Revvity, Inc. (46.27), less than Penumbra, Inc. (73.18), less than DaVita Inc. (18.00), less than Atrium Therapeutics, Inc. (-3.27), less than Caris Life Sciences, Inc. (149.42),
| Company | PE Ratio | Market cap |
|---|---|---|
| 19.08 | $7.64B | |
| 45.67 | $7.73B | |
| -9.78 | $10.77B | |
| -11.55 | $6.41B | |
| 46.27 | $11.12B | |
| 73.18 | $12.54B | |
| 18.00 | $13.40B | |
| -3.27 | $211.60M | |
| 149.42 | $5.08B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Charles River Laboratories International, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Charles River Laboratories International, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Charles River Laboratories International, Inc.'s PE Ratio?
How is the PE Ratio calculated for Charles River Laboratories International, Inc. (CRL)?
What is the highest PE Ratio for Charles River Laboratories International, Inc. (CRL)?
What is the 3-year average PE Ratio for Charles River Laboratories International, Inc. (CRL)?
What is the 5-year average PE Ratio for Charles River Laboratories International, Inc. (CRL)?
How does the current PE Ratio for Charles River Laboratories International, Inc. (CRL) compare to its historical average?